Author:
Igetei R.,Otegbayo J. A.,Lesi O. A.,Anumudu C. I.,Ndububa D. A.
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Olubuyide IO, Aliyu B, Olaleye OA, et al (1997) Hepatitis B and C virus and hepatocellular carcinoma. Transactions of the Royal Society of Trop Med and Hyg 91:38–41
2. Gashau W, Mohammed I (1991) Hepatitis B viral markers in Nigerian patients with primary liver cell carcinoma. Trop and Geog Med 43:64–67
3. Olubuyide IO (1992) Natural history of primary liver cell carcinoma. A study of 89 untreated adult Nigerians. Centr Afr J Med. 38:25–30
4. Kirk GD, Lesi OA, Mendy M, et al (2005) 249ser TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma. Oncogene 24:5858–5867
5. Coursaget P, Bourdil C, Kastally R, et al (1990) Prevalence of hepatitis C virus infection in Africa: anti-HCV antibodies in the general population and in patients suffering from cirrhosis or primary liver cancer. Res Virol 141:449–454